Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
This brief explains the asset selection logic behind equal weighted indices and how different asset classes impact portfolio balance.
23,793 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
A fresh take on spotting a possible dark-horse in the driverless vehicle arena. Learn the signals, risks, and how to ...
Iran publicly spurns ceasefire talks amid renewed attacks, while the White House insists talks continue. The flare-up...
A rising trend among affluent couples sees them drawing down the 401K early while delaying Social Security to 70, loc...
Bond markets flash warning signs as U.S. yields push toward multi-decade highs and Bitcoin trades below $80,000 amid ...
Two AI models clash on XRP's path to $3 by Q4 as regulatory, liquidity, and macro factors shape divergent bets from t...
A new wave of headlines around Nebius stock is stirring debate among investors. This guide breaks down what the news ...
GraniteShares’ 2x COIN ETF has seen substantial NAV erosion as Coinbase volatility spikes, prompting renewed debate o...
Gate teams up with Alpaca to offer real stock trading to users worldwide, bridging crypto and traditional markets wit...
Galaxy Digital lowers its odds on the CLARITY Act, putting clarity chances passage this year at 60% as lawmakers rush...
When veterans return with their first original album in years, the headlines focus on the music. What truly stands ou...
Investors are increasingly able to invest real estate with limited capital by using leverage, partnerships, and platf...